Physicians often use anticoagulant
drugs to prevent blood clots in patients recuperating from heart attacks, stroke or major surgery, but not without risking serious side effects.
Peri-operative management of oral anticoagulants
and antiplatelet agents
It is transitioning from a market dominated by a single injectable anticoagulant
to a highly competitive one dominated by first-in-class novel oral anticoagulants
The launch and rapid uptake of new oral anticoagulants
, atrial-selective antiarrhythmic drugs, and the expanding prevalent patient population will be the key drivers of market growth.
They are classified as anticoagulants
, and others depending on how they work.
A new report by visiongain predicts that the overall world antithrombotic and anticoagulant
drug market will reach 24.
About Endotis Endotis Pharma is a world leader in the development of neutralizable anticoagulants
used in cardiac surgery.
Because the tool is not specific to any single drug product or care setting, it can evaluate clinical communications relating to all currently available anticoagulants
as well as newly marketed agents as they arrive, states Myrka.
Our report, Anticoagulants
in Stroke Prevention in Atrial Fibrillation (SPAF): Novel Oral Anticoagulants
with Superior Safety Profile will Drive the Market provides key data, information on Anticoagulants
in Stroke Prevention in Atrial Fibrillation.
The unmet medical needs of available anticoagulants
offer ample scope for development in the world anticoagulants
July 23, 2014 /PRNewswire/ -- Decision Resources Group finds that novel oral anticoagulants
(NOACs) such as Xarelto, Boehringer Ingelheim's Pradaxa and Bristol-Myers Squibb/Pfizer's Eliquis are preferred treatments for venous thromboembolism (VTE), atrial fibrillation (AF) and acute coronary syndrome (ACS) among physicians and payers in Brazil and Mexico.
Market II-1 Global Market Overview II-1 Current and Future Scenario II-1 Major Markets - Products II-1 Injectable Anticoagulants
- On An Up Trend II-1 Low Molecular Weight Heparins - Ruling the Roost II-1 Major Markets - Regional II-2 United States - The Largest Market II-2 Europe - The Second Largest Market II-2
This makes learning about anticoagulants
Data from 9,652 atrial fibrillation (AF) patients who received care through Aurora Health Care during the 4-year period also showed that two new oral anticoagulants
, rivaroxaban (Xarelto) and dabigatran (Pradaxa), seemed roughly comparable to warfarin for preventing strokes and not causing bleeding, including in patients aged 80 years or older, a patient group poorly represented in the pivotal trials of the new drugs, Dr.
com/research/vgwhc9/new_oral) has announced the addition of the "Concise Analysis of the International New Oral Anticoagulants
Markets" report to their offering.